LigaSure Celebrates 25 Years and 35 Million Procedures: The Market-Leading Vessel Sealing System Files for IPO

Jul 09, 2025 11:30 CST Updated 11:30

Medtronic

Medical Device Manufacturer

MedtronicMedtronic on Social MediaAnnounced: LigaSURE series has been on the market for 25 years, completing over 35 million surgeries.LigaSureIt can be said to be the most successful large blood vessel product currently on the market.The Closer, LigaSure occupies 78% of the large vessel closure market in the United States, and in Europe, LigaSure maintains its market leadership (accounting for about 50% of the market). However, in China, due to usage habits,LigaSure's commercial performance is unsatisfactory, clearly lagging behind in the competition with ultrasonic scalpels.

In 25 years, in addition to completing 35 million surgeries, Medtronic has also completed over 1,300 clinical studies to provide evidence.Safety and Effectiveness of the LigaSure Product Series

LigaSure, known in Chinese as the 结扎速血管闭合系统 (Ligasure Vessel Sealing System), also called the Electrothermal Bipolar Vessel Sealer (EBVS), is an intelligent bipolar system. The LigaSure Vessel Sealing System combines real-time feedback technology with intelligent host technology, automatically identifying and providing continuous feedback on tissue impedance between the jaws, while instantly adjusting the output of current and voltage. Combined with increased pressure from the electrocautery forceps, it denatures and fuses collagen and fibrin in the blood vessel walls, creating a transparent band that results in permanent lumen closure. This transparent band can withstand three times the systolic arterial pressure of the human body. It can safely seal various blood vessels within 7mm and is also suitable for handling ligaments and tissue bundles.

Medtronic has successively launched dozens of products in 25 years.LigaSureSeries products, currently there are still 14 models on its official website.LigaSureProducts. TheseLigaSureThe product can be used for both minimally invasive endoscopic surgery and open surgery, meeting the needs of various surgeries in general surgery.

With the development of surgical medical technology, Medtronic this yearFirst Launch of Soft Tissue Surgical Robot at SRS 2025 ConferenceLigaSure RAS Maryland. Enable Hugo to use advanced energy electrosurgical products.LigaSure, allowing Hugo to have advanced instruments, while also providingLigaSureLay the foundation for future development.